Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


04:45 Wednesday, August 12, 2020


RTTNews | Aug 12, 2020 04:45PM EDT

04:45 Wednesday, August 12, 2020

|BEGINSUB|Asian Shares Mixed In Cautious Trading|ENDSUB|Asian stocks ended mixed in cautious trading on Wednesday as Russia's announcement that its coronavirus vaccine has been approved was offset by worries about a political holdup in Washington over coronavirus relief.

|BEGINSUB|European Stock Markets Finish In The Green|ENDSUB|The European stock markets shrugged off a listless open on Wednesday and picked up steam as the day progressed, ending their sessions firmly in positive territory for the third straight day.The markets moved higher after data showed factory output in the euro zone grew for the second straight month in June, following a marked relaxation of the coronavirus containment measures.

|BEGINSUB|Tech Stocks Lead Significant Rebound On Wall Street|ENDSUB|Following the sharp pullback seen late in the previous session, stocks showed a strong move back to the upside during trading on Wednesday. The major averages more than offset Tuesdays losses, with the S&P 500 climbing back within striking distance of its record highs.

|BEGINSUB|Stock Alert: Monopar Therapeutics Surges On Novel Triage Test Plan For Severe COVID-19 |ENDSUB|Shares of Monopar Therapeutics Inc. are gaining more than 62 percent or $4.63 in Wednesdays morning trade at $12.02.

Wednesday, Monopar Therapeutics said its plans to develop a test to potentially triage COVID-19 patients into those likely versus unlikely to progress to severe respiratory failure. The test would use Monopars proprietary monoclonal antibody, ATN-658, to detect soluble urokinase plasminogen activator receptor (suPAR) in COVID-19 patient plasma.

|BEGINSUB|Stock Alert: Pacific Biosciences Of California Rises 22%; Prices Public Offering |ENDSUB|Shares of Pacific Biosciences of California, Inc. (TS:PACB) are climbing almost 22 percent or $0.97 in Wednesdays morning trade at $5.44.

Tuesday, Pacific Biosciences priced its previously announced public offering of 19.43 million common shares at $4.47 per share. The offering is expected to close on or about August 14, 2020.

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2008 RealTimeTraders.com, Inc. All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-5
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC